BENZYL-2-(3S-3-[[(1,1-DIMETHYLOXY)-CARBONYL]-AMINO]-2,5-DIOXO-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPIN-1-YL)-ETHANOATE
Compound with spectra: 1 NMR
![BENZYL-2-(3S-3-[[(1,1-DIMETHYLOXY)-CARBONYL]-AMINO]-2,5-DIOXO-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPIN-1-YL)-ETHANOATE](/api/compound/GX04XOwN7c3.png?ph=true&h=300&w=458 "BENZYL-2-(3S-3-[[(1,1-DIMETHYLOXY)-CARBONYL]-AMINO]-2,5-DIOXO-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPIN-1-YL)-ETHANOATE")
| SpectraBase Compound ID | GX04XOwN7c3 |
|---|---|
| InChI | InChI=1S/C24H26N2O6/c1-24(2,3)32-23(30)25-18-13-20(27)17-11-7-8-12-19(17)26(22(18)29)14-21(28)31-15-16-9-5-4-6-10-16/h4-12,18H,13-15H2,1-3H3,(H,25,30)/t18-/m1/s1 |
| InChIKey | MYDYZGRXMJIFMM-GOSISDBHSA-N |
| Mol Weight | 438.48 g/mol |
| Molecular Formula | C24H26N2O6 |
| Exact Mass | 438.179087 g/mol |
| Enantiomer InChIKey | MYDYZGRXMJIFMM-SFHVURJKSA-N |
| Racemate InChIKey | MYDYZGRXMJIFMM-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-[3-(tert-butoxycarbonylamino)-2,5-diketo-3,4-dihydro-1-benzazepin-1-yl]acetic acid ethyl ester
2-(3S-3-[[(1,1-DIMETHYLOXY)-CARBONYL]-AMINO]-2,5-DIOXO-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPIN-1-YL)-ETHANOATE
Benazepril 2ME II
Benazepril-M/artifact iso-1 4ME @
Benazepril-M/artifact 3ME @
1,13-Diazatricyclo[10.3.1.0(2,7)]hexadeca-2(7),3,5-triene-8,16-dione, 13-acetyl-5-methyl-
(S)-7-Chloro-1-benzyl-3-[(methoxycarbonyl)methyl]-1,4-benzodiazepine-2,5-dione
1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione, 2,3-dihydro-10-(3-methylbutyl)-
ethyl (2,4-dioxo-3-(tetrahydro-2-furanylmethyl)-3,4-dihydro-1(2H)-quinazolinyl)acetate
1-acetyl-2-(2-bromophenyl)-2,3-dihydroquinolin-4(1H)-one
| Title | Journal or Book | Year |
|---|---|---|
| Syntheses and conformational analyses of some 3-amino-2,5-dioxo-2,3,4,5-tetrahydro-1H-1-benzazepine derivatives: X-ray crystal structure of 35-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,5-dioxo-2,3,4,5-tetrahydro-1H-1-benzazepine | Journal of Heterocyclic Chemistry | 1990 |